For the past 6-months our team at MS Money Moves has been following the story of DelMar Pharmaceuticals (NASDAQ: DMPI) in an effort to educate and inform the investment community. During this time, we … [Read more...] about DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
GBM
DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
Recap: Since November of 2019 MS Money Moves has been following DelMar Pharmaceuticals (Nasdaq: DMPI) closely through a number of key value inflection points. In my initial article I … [Read more...] about DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
On September 25th, 2019 the MS Money Moves Executive Leadership Team had an hour long conference call with President and CEO of DelMar Pharmaceuticals (Nasdaq: DMPI) Saiid Zarrabian and acting Chief … [Read more...] about Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
You must be logged in to post a comment.